Donepezil-associated survival benefits among Alzheimer’s disease patients are retained but not enhanced during COVID-19 infections

BACKGROUND AND AIM: Donepezil is a front-line treatment for Alzheimer’s disease. Donepezil treatment is associated with decreased risk of all-cause mortality. Specific protection is observed in pneumonia and cardiovascular disease. We hypothesized that donepezil treatment would improve mortality amo...

Descripción completa

Detalles Bibliográficos
Autores principales: Edmiston, Elizabeth A., Bej, Taissa A., Wilson, Brigid, Jump, Robin L. P., Phillips, Joy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203853/
https://www.ncbi.nlm.nih.gov/pubmed/37234745
http://dx.doi.org/10.1177/20499361231174289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203853/
https://www.ncbi.nlm.nih.gov/pubmed/37234745
http://dx.doi.org/10.1177/20499361231174289

Ejemplares similares